Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: The Edinburgh type 2 diabetes study

Diabetes

Volumn 59, Issue 11, 2010, Pages 2883-2889

  Ding, Jie ^a   Strachan, Mark W J ^b   Reynolds, Rebecca M ^a   Frier, Brian M ^a,c   Deary, Ian J ^a   Fowkes, F Gerald R ^a   Lee, Amanda J ^d   McKnight, Janet ^e   Halpin, Patricia ^e   Swa, Ken ^e   Price, Jackie F ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e PRINCESS ALEXANDRA EYE PAVILION   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; DEMOGRAPHY; DEPRESSION; DIABETIC RETINOPATHY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SEX DIFFERENCE; VERBAL BEHAVIOR;

AGED; CEREBROVASCULAR CIRCULATION; COGNITION; COGNITION DISORDERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; EDUCATIONAL STATUS; FEMALE; HEALTH SURVEYS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MEMORY; MIDDLE AGED; SCOTLAND; SEX CHARACTERISTICS; VISION, BINOCULAR; VISUAL ACUITY;

EID: 78049299161     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-0752     Document Type: Article

References (45)

1. Cukierman T, Gerstein HAC, Williamson JD. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005;48:2460-2469
2. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5:64-74 (Pubitemid 41790697)
3. Sander D, Sander K, Poppert H. Stroke in type 2 diabetes. Br J Diabetes Vasc Dis 2008;8:222-229
4. Starr JM, Wardlaw J, Ferguson K, MacLullich A, Deary IJ, Marshall I. Increased blood-brain barrier permeability in type 2 diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2003;74:70-76
5. Manschot SM, Brands AM, van der Grond J, Kessels RP, Algra A, Kappelle LJ, Biessels GJ. Brian magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 2006;55:1106-1113
6. van Harten B, Oosterman J, Muslimovic D, van Loon BJ, Scheltens P, Weinstein HC. Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing 2007;36:164-170 (Pubitemid 46455395)
7. Patton N, Aslam T, Macgillivray T, Pattie A, Deary IJ, Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease : a rationale based on homology between cerebral and retinal microvasculatures. J Anat 2005;206:319-348
8. Kwa VI, van der Sande JJ, Stam J, Tijmes N, Vrooland JL. Retinal arterial changes correlate with cerebral small-vessel disease. Neurology 2002;59:1536-1540
9. Wong TY, Klein R, Sharrett AR, Couper DJ, Klein BE, Liao DP, Hubbard LD, Mosley TH. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002;288:67-74
10. Cooper LS, Wong TY, Klein R, Sharrett AR, Bryan RN, Hubbard LD, Couper DJ, Heiss G, Sorlie PD. Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke 2006;37:82-86
11. Cheung N, Wong TY. Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res 2008;27:161-176
12. Ferguson SC, Blane A, Perros P, McCrimmon RJ, Best JJ, Wardlaw J, Deary IJ, Frier BM. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 2003;52:149-156
13. Ding J, Patton N, Deary IJ, Strachan MW, Fowkes FG, Mitchell RJ, Price JF. Retinal microvascular abnormalities and cognitive dysfunction: a systematic review. Br J Ophthalmol 2008;92:1017-1025
14. Liew G, Mitchell P, Wong TY, Lindley RI, Cheung N, Kaushik S, Wang JJ. Retinal microvascular signs and cognitive impairment. J Am Geriatr Soc 2009;57:1892-1896
15. Lesage SR, Mosley TH, Wong TY, Szklo M, Knopman D, Catellier DJ, Cole SR, Klein R, Coresh J, Coker LH, Sharrett AR. Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study. Neurology 2009;73:862-868
16. Price JF, Reynolds RM, Mitchell RJ, Williamson RM, Fowkes FG, Deary IJ, Lee AJ, Frier BM, Hayes PC, Strachan MW. The Edinburgh Type 2 Diabetes Study: study protocol. BMC Endocr Disord 2008;8:18-28
17. Marioni RE, Strachan MW, Reynolds RM, Lowe GD, Mitchell RJ, Fowkes FG, Frier BM, Lee AJ, Butcher I, Rumley A, Murray GD, Deary IJ, Price JF. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 2010;59:710-713
18. Wechsler D. Manual of the Wechsler Memory Scale - Revised. New York, Psychological Corporation, 1987
19. Wechsler D. Wechsler Adult Intelligence Scale (UK). 3rd ed. London, Psychological Corporation, 1998
20. Lezak M. Neuropsychological Assessment. 3rd ed. Oxford, Oxford University Press, 1995
21. Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, Oxford University Press, 1991
22. Raven J, Raven JC, Court JH. Manual for Raven's Progressive Matrices and Vocabulary Scales. Oxford, U.K., Oxford Psychologists Press, 1998
23. Salthouse TA. Localizing age-related individual differences in a hierarchical structure. Intelligence 2004;32:541-561
24. Deary IJ, Whalley LJ, Crawford JR. An 'instantaneous' estimate of a lifetime's cognitive change. Intelligence 2004;32:113-119
25. Crawford JR, Deary IJ, Starr J, Whalley LJ. The NART as an index of prior intellectual functioning: a retrospective validity study covering a 66-year interval. Psychol Med 2001;31:451-458
26. Folstein MF, Folstein SE. Mini Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975;12:189-198
27. Zigmond AS, Snaith RP. The hospital anxiety and depression scales. Acta Psychiatr Scand 1983;67:361-370
28. Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med 1977;31:42-48
29. Leng GC, Fowkes FG: The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992;45:1101-1109
30. Early Treatment Diabetic Retinopathy Study Research Group: Grading diabetic retinopathy fromstereoscopic color fundus photographs: an extension of the modified Airlie House classification: ETDRS report number 10. Ophthalmology 1991;98:786-806
31. Early Treatment Diabetic Retinopathy Study Research Group: Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report number 12. Ophthalmology 1991;98:823-833
32. Dawson D. Methodological issues in measuring alcohol use. Alcohol Res Health 2003;27:18-29
33. SPSS for Windows. Chicago, IL, SPSS Inc., 2004
34. Manschot SM, Biessels GJ, de Valk H, Algra A, Rutten GE, van der Grond J, Kappelle LJ. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 2007;50:2388-2397
35. Umegaki H, Iimuro S, Kaneko T, Araki A, Sakurai T, Ohashi Y, Iguchi A, Ito H. Factors associated with lower Mini Mental State Examination scores in elderly Japanese diabetes mellitus patients. Neurobiol Aging 2008;29:1022-1026
36. Baker ML, Marino Larsen EK, Kuller LH, Klein R, Klein BE, Siscovick DS, Bernick C, Manolio TA, Wong TY. Retinal microvascular signs, cognitive function, and dementia in older persons. Stroke 2007;38:2041-2047
37. Wong TY, Klein R, Sharrett AR, Nieto FJ, Boland LL, Couper DJ, Mosley TH, Klein BE, Hubbard LD, Szklo M. Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke 2002;33:1487-1492 (Pubitemid 34619944)
38. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW, Masaki K, Launer L, Markesbery WR. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci 2002;977:9-23 (Pubitemid 35418132)
39. Vermeer SE, Prins ND, Den HT, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-1222
40. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koudstaal PJ, Hofman A, Breteler MM. Cerebral small vessel disease and decline in information processing speed, executive function and memory. Brain 2005;128:2034-2041
41. van der Flier WM, van Straaten EC, Barkhof F, Verdelho A, Madureira S, Pantoni L, Inzitari D, Erkinjuntti T, Crisby M, Waldemar G, Schmidt R, Fazekas F, Scheltens P. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke 2005;36:2116-2120
42. Farrall AJ, Wardlaw JM. Blood-brain barrier: ageing and microvascular disease-systematic review and meta-analysis. Neurobiol Aging 2009;30:337-352
43. Coker LH, Shumaker SA. Type 2 diabetes mellitus and cognition: an understudied issue in women's health. Psychosom Res 2003;54:129-139
44. Deary IJ, Whiteman MC, Pattie A, Starr JM, Hayward C, Wright AF, Carothers A, Whalley LJ: Cognitive change and the APOE epsilon 4 allele. Nature 2002;418:932
45. Stewart MC, Deary IJ, Fowkes FG, Price JF. Relationship between lifetime smoking, smoking status at older age and human cognitive function. Neuroepidemiology 2006;26:83-92